HomeVenture Capital

Venture Capital

Venture Capital

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases

Life Sciences Times - March 25, 2025

Venture Capital

Venture Capital Fundraising in Healthcare Remains Healthy

Life Sciences Times - March 21, 2025

Venture Capital

Wheeler Bio Announces Oversubscribed $35M Series, Plans for Expansion and Continued Growth

Life Sciences Times - March 20, 2025

Venture Capital

Pandion Optimization Alliance Becomes Nation’s Leading Women’s Healthcare GPO with Acquisition of Blackmaple Group

Life Sciences Times - March 17, 2025

Venture Capital

QT Imaging Holdings Successfully Uplisted to OTCQB

Life Sciences Times - March 17, 2025

Venture Capital

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing

Life Sciences Times - February 3, 2025 0

Venture Capital

AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch

Life Sciences Times - January 28, 2025 0

Venture Capital

Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program

Life Sciences Times - January 14, 2025 0

Venture Capital

Cycle Pharma Acquires Banner Life Sciences, LLC

Life Sciences Times - January 13, 2025 0

Venture Capital

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Life Sciences Times - January 8, 2025 0

Venture Capital

Transcarent To Acquire Accolade

Life Sciences Times - January 8, 2025 0

Venture Capital

KARL STORZ Acquires Medical Business of Visual Collaboration Software Company T1V

Life Sciences Times - January 8, 2025 0

Venture Capital

Klick Health Acquires Peregrine Market Access

Life Sciences Times - January 7, 2025 0

Venture Capital

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles

Life Sciences Times - January 6, 2025 0

Venture Capital

MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio

Life Sciences Times - January 6, 2025 0

Venture Capital

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Life Sciences Times - December 18, 2024 0

People on the Move

Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding

Life Sciences Times - December 12, 2024 0

123...95 Page 2 of 95

Most Read

BioMed Realty Acquires 75 Broadway, a Life Science Development to be Biogen’s New Global Headquarters

March 25, 2025

athenahealth Releases Annual Physician Survey

March 25, 2025

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases

March 25, 2025

Suffolk Hires Experienced Construction Leader Evan McKee as COO in Dallas to Drive Regional Growth and Diversification

March 25, 2025

EDITOR PICKS

Biogen Will Have a New Global Headquarters and Innovation Hub in Kendall Square in Cambridge, MA

March 25, 2025

Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection

March 23, 2025

Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards

March 21, 2025

THIS WEEK'S STORIES

ABI-LAB Co-Founder Gary Kaufman to Speak at Boston Life Sciences Conference

March 20, 2025

Revvity Expands Alliance with Genomics England

March 20, 2025

Surgical Robotic System Market Projected to Reach $16.82 Billion by 2034

March 24, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv